Antimicrobial cationic peptides
AssigneeThe University of British Columbia
InventorsTimothy J. Falla, Robert E.W. Hancock, Monisha Gough
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of British Columbia
InventorsTimothy J. Falla, Robert E.W. Hancock, Monisha Gough
Estimating the term…
A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X1X1PX2X3X2P(X2X2P)nX2X3(X5)0; (SEQ ID NO: 23) X1X1PX2X3X4(X5)rPX2X3X3; (SEQ ID NO: 24) X1X1X3(PW)uX3X2X5X2X2X5X2(X5)0; and (SEQ ID NO: 25) X1X1X3X3X2P(X2X2P)nX2(X5)m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X2 represents Tryptophan or Phenylalanine X3 represents Arginine or Lysine; X4 represents Tryptophan or Lysine; and X5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity.
An isolated cationic peptide having antimicrobial activity and an amino acid sequence selected from the group consisting of:
An isolated cationic peptide having antimicrobial activity and an amino acid sequence selected from the group consisting of:
A method for inhibiting the growth of a bacterium or yeast comprising contacting the bacterium or yeast with an inhibiting effective amount of a peptide having an amino acid sequence selected from the group consisting of:
A method for inhibiting the growth of a bacterium or yeast comprising contacting the bacterium or yeast with an inhibiting effective amount of a peptide having an amino acid sequence selected from the group consisting of:
A method for inhibiting an endotoxemia or sepsis associated disorder in a subject having or at risk of having such a disorder, comprising administering to the subject a therapeutically effective amount of a cationic peptide having antimicrobial activity and an amino acid sequence selected from the group consisting of:
A method for inhibiting an endotoxemia or sepsis associated disorder in a subject having or at risk of having such a disorder, comprising administering to the subject a therapeutically effective amount of a cationic peptide having antimicrobial activity and an amino acid sequence selected from the group consisting of:
A method for producing a cationic peptide variant having antimicrobial activity comprising:
Dependencies are inferred from the claim text.